, Cancer incidence and mortality worldwide: IARC CancerBase No, International Agency for Research on Cancer, 2013.
The geographical pathology of primary liver cancer, Cancer Res, vol.23, pp.1624-1657, 1963. ,
Health economic impacts and cost-effectiveness of aflatoxin reduction strategies in Africa: case studies in biocontrol and postharvest interventions, Food Addit Contam, vol.27, pp.496-509, 2010. ,
The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions, BMC Infect Dis, vol.12, p.131, 2012. ,
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium, Lancet Gastroenterol Hepatol, vol.2, pp.103-114, 2017. ,
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa, Nature, vol.350, pp.429-460, 1991. ,
In human hepatocellular carcinoma, chromosome instability depends on p53 status and aflatoxin exposure, Mutat Res, vol.653, pp.6-13, 2008. ,
Mutation spectrum of hepatocellular carcinoma from Eastern-European patients betrays the impact of a complex exposome, J Exp Sci Environ Epidemiol, vol.25, pp.256-63, 2014. ,
Early forms of liver cancer in South America associate with low hepatitis B virus DNA burden ,
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy, Cancer Lett, vol.286, pp.29-37, 2009. ,
Les acides nucléiques du plasma sanguin chez l'Homme, CR Soc Biol, vol.142, pp.241-244, 1948. ,
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers, Br J Cancer, vol.96, pp.681-686, 2007. ,
Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool, Clin Chem, vol.52, pp.1833-1875, 2006. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014. ,
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat Med, vol.20, pp.430-435, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168071
Problem of hepatocellular carcinoma in West Africa, World J Hepatol, vol.6, pp.783-92, 2014. ,
ROC analysis: web-based calculator for ROC curves, 2014. ,
A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa, BMC Infect Dis, vol.16, p.647, 2016. ,
A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention, Cancer Lett, vol.286, pp.22-30, 2009. ,
Hepatocellular carcinoma: from gene to public health, J Natl Cancer Inst, vol.89, pp.1844-51, 1997. ,
p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer, Mutat Res, vol.428, pp.23-32, 1999. ,
Current and emerging applications of droplet digital PCR in oncology, Mol Diagn Ther, vol.21, pp.493-510, 2017. ,
Comparison of three different DNA extraction methods from a highly degraded biological material, J Forens Leg Med, vol.40, pp.47-53, 2016. ,
Detection of a tumor suppressor gene variant predisposing to colorectal cancer in an 18th century Hungarian mummy, PLoS ONE, vol.11, p.147217, 2016. ,
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nat Genet, vol.47, pp.505-516, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01159736
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia, J Natl Cancer Inst, vol.92, pp.148-53, 2000. ,
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry, Cancer Res, vol.61, pp.33-38, 2001. ,
Genetic heterogeneity of hepatocellular carcinoma, Proc Natl Acad Sci USA, vol.91, pp.822-828, 1994. ,
A peculiar mutation spectrum emerging from young Peruvian patients with hepatocellular carcinomas, PLoS ONE, vol.9, p.114912, 2014. ,
Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma, World J Hepatol, vol.2, pp.94-102, 2010. ,
Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, BMC Infect Dis, vol.15, p.180, 2015. ,
249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma, J Gastroenterol Hepatol, vol.20, pp.1185-90, 2005. ,
Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cellfree DNA, Ann Hepatol, vol.7, pp.339-383, 2008. ,
Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon, Int J Environ Res Public Health, vol.7, pp.178-88, 2010. ,
Multimycotoxin analysis in urines to assess infant exposure: a case study in Cameroon, Environ Int, vol.58, pp.50-59, 2013. ,
Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach, Food Chem Toxicol, vol.62, pp.927-961, 2013. ,
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma, Oncogene, vol.24, pp.5858-67, 2005. ,
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry, Cancer Epidemiol Biomark Prev, vol.14, pp.2956-62, 2005. ,
Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma, Arch Med Sci, vol.3, pp.348-55, 2010. ,
The effect of preservative and temperature on the analysis of circulating tumor DNA, Clin Cancer Res, vol.23, pp.2471-2478, 2017. ,
Optimizing the yield and utility of circulating cell-free DNA from plasma and serum, Clin Chim Acta, vol.404, pp.100-104, 2009. ,
Circulating free DNA in the era of precision oncology: pre-and post-analytical concerns, Chron Dis Transl Med, vol.2, pp.223-253, 2016. ,
Methods for isolation of cellfree plasma DNA strongly affect DNA yield, Clin Chim Acta, vol.412, pp.2085-2093, 2011. ,
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma, World J Hepatol, vol.7, pp.1054-63, 2015. ,
Percutaneous ablation of hepatocellular carcinoma: current status, J Vasc Interv Radiol, vol.21, pp.204-217, 2010. ,